Connect with:
Friday / March 29. 2024
HomePosts Tagged "Bayer CropScience Limited"

Company’s Profit Before Tax stood at Rs 1,242 million as compared to Rs 1,836 million in the corresponding period of FY 2022-23.

Bayer CropScience Limited has announced its unaudited results for the quarter and nine months ended December 31, 2023. In the third quarter (Q3) of Financial Year (FY) 2023-24, Bayer CropScience Limited (BCSL) earned Revenue from Operations of Rs 9,549 million, as compared to Rs 10,379 million in the corresponding period of FY 2022-23. Profit Before Tax (Before Exceptional Items) stood at Rs 1,242 million, compared to Rs 829 million in the corresponding period of FY 2022-23. Profit Before Tax (After Exceptional Items) stood at Rs 1,242 million as compared to Rs 1,836 million in the corresponding period of FY 2022-23.

For the nine months ended December 31, 2023, BCSL reported Revenue from Operations of Rs 43,117 million, compared to Rs 41,572 million for the corresponding period in FY 2022-23. Profit Before Tax (Before Exceptional Items) for the nine months ended December 31, 2023, stood at Rs 8,360 million, compared to Rs 6,942 million for the corresponding period in FY 2022-23. Profit Before Tax (After Exceptional Items) stood at ₹ 8,360 million as compared to Rs7,949 million in the corresponding period of FY 2022-23.

Commenting on the quarterly performance, Simon Wiebusch, Vice Chairman/Managing Director and CEO, BCSL said, “An erratic monsoon led to low water reservoir levels. The resulting crop shifts and missed sprays, had an unfavorable impact on our quarterly sales performance owing to lower volumes and sales returns. While Crop Protection liquidation has been sluggish on the back of the weak season, we actively managed rebates and discounts and thus maintained our margins to a large extent. A more diversified corn footprint supported seeds sales. We continue to steadily expand our efforts in support of the Government’s collectivization endeavors by reaching out to 3000+ Farmer Producer Organizations (FPOs), of which 10 belong to women, with BCSL supporting the creation of over 110 FPOs in the country. Also, we continue to focus on Better Life Farming as our extended smallholder farmer go to market.”

Simon Britsch, Chief Financial Officer, BCSL said, “We continued our efforts and focused on optimizing our operating expenses, achieving sizable efficiencies in the past 9 months. We were thus able to expand our profit margins in a difficult market environment. While managing operating expenses, we continue to make significant investments into future growth and market reach.”

Company’s Profit Before Tax stood at Rs

Malu Nachreiner to become new commercial lead for Asia Pacific, both effective March 1, 2024.

Bayer is applying several key changes to the Executive Leadership Team of its Crop Science Division. The new setup will support the company to shape agriculture for farmers, consumers, and the planet, and to deliver against the ambition of becoming the leader in regenerative agriculture.

Brian Naber will assume the position as commercial lead for the region North America from Jackie Applegate who will be retiring from Bayer after 31 years with the company. Consequently, Malu Nachreiner, currently serving as Senior Bayer Representative and Country Division Head for Crop Science in Brazil, is going to succeed Brian Naber as commercial lead for the region Asia Pacific. Both changes will become effective as of March 1, 2024. As of February 1, Oliver Rittgen will serve as the division’s new Chief Financial Officer following Kelly Gast who retired after almost 30 years with the company. Oliver’s current assignment is Chief Financial Officer for Bayer’s Consumer Health Division.

Further changes have become effective with the beginning of 2024: Sascha Israel has been appointed as Head of Product Supply succeeding Dirk Backhaus who retired after 27 years with Bayer. Amanda McClerren, former Head of Crop Science R&D Digital Transformation and Information Technology is going to take over Sascha’s former role as Chief Information Officer, Head of Digital Transformation and Information Technology. Finally, Jessica Christiansen assumes the position as Head of Crop Science Communications after having led the division’s Sustainability and Business Stewardship Team. She is taking over from Tom Armitage who decided to pursue further career opportunities outside of Bayer.

“With the new setup of the Crop Science Executive Leadership Team, we are perfectly positioned to further drive our vision of regenerative agriculture and to deliver much needed innovations to farmers,” said Rodrigo Santos, member of the Board of Bayer AG and president of the company’s Crop Science division. “I am looking forward to working together with this team to tackle some of the most important topics of our time: achieving food security and fighting climate change at the same time. To this end, we will continue to support our customers to produce more while restoring more. I would like to thank Jackie, Kelly, Dirk, and Tom for their dedicated service to Bayer and their outstanding achievements over the last years. They all will leave a lasting legacy, in particular for the Crop Science division.”

Malu Nachreiner to become new commercial lead

FSII ropes in Ajai Rana, CEO, Savannah Seeds as Chairman of the Board of Directors and Shirish Barwale, Director, Maharashtra Hybrid Seeds Company as Vice Chairman.

Federation of Seed Industry of India (FSII), the prominent industry association of R&D based seed companies in India, is delighted to announce the successful leadership transition with Ajai Rana, CEO, Savannah Seeds Private Limited, assuming the role of the Chairman of the Board of Directors. FSII held its Annual General Meeting on 25 Sep 2023, which marked the occasion of the new leadership team formally taking over the mantle.

 Rajvir Rathi, Head – Public Affairs, Science & Sustainability IBSL and Lead – Traits Licensing Business, Bayer CropScience Limited and Shirish Barwale, Director, Maharashtra Hybrid Seeds Company Private Limited, assumed the roles of Vice Chairmen. Dr Venkatram Vasantavada, MD & CEO, SeedWorks International Private Limited, took charge as the Finance Director. 

The new leadership team expressed their profound gratitude for the dedicated efforts of the founding and former Board members who, since its inception, have been instrumental in shaping FSII into a respected industry association at the forefront of India’s seed sector.

FSII’s rich legacy, built upon the vision and relentless dedication of these early pioneers, has led to its establishment as a pioneering industry association for the Indian seed sector. Over the years, FSII has achieved remarkable growth, recognition, and respect within the industry, primarily due to the tireless commitment of those who have steered its course.

Under the guidance of the newly appointed leadership, FSII is now poised to take its mission to the next level. With a renewed focus on becoming a ‘knowledge-driven’ federation of research-based seed companies in India, FSII aims to contribute significantly to the growth and development of the Indian seed sector. The organization envisions a future where innovative research, sustainable practices, and knowledge-sharing will drive the industry to new heights.

“On behalf of the new leadership team, we acknowledge the great efforts of our founding and former leadership who have brought FSII to what it is today as the voice of Indian seed sector. FSII is ready to embrace the challenges and opportunities of the future, leading the way towards a knowledge-driven and prosperous Indian seed sector. Our commitment is unwavering, and we are determined to build upon the strong foundation laid by our predecessors. As we embark on this exciting journey of leadership continuity and renewed focus, we invite all the industry stakeholders, partners, and collaborators to join hands with us in shaping the future of the Indian seed sector. Together, we can collectively contribute to the growth, sustainability, and prosperity of this most important industry.” said Ajai Rana on the occasion.

FSII’s leadership transition represents a vital step on the continuum of progress, ensuring that the organization remains relevant, dynamic, and influential in the years to come. The new team is dedicated to preserving the values and vision of FSII while simultaneously adapting to the evolving needs of the industry.

Focusing on strategic stakeholder engagement and targeted policy advocacy, FSII is all set to bolster its collaboration with Central and State governments, various Ministries, departments, and statutory bodies to ensure that policy and regulatory frameworks are holistic and conducive to the growth of the seed industry and aligned with nation’s Amrit Kaal aspirations.

This leadership transition not only ensures that FSII remains agile and expands its sphere of influence in the ever-evolving Indian seed industry but also places a strong emphasis on fostering enhanced collaboration and communication with key stakeholders.

FSII will actively seek collaboration and partnerships with industry players, research institutions, academia, scientific fraternity, and other stakeholders to drive innovation and knowledge exchange within the sector. FSII committed to disseminating industry insights and promoting best practices among its members and stakeholders.

FSII ropes in Ajai Rana, CEO, Savannah

 Company’s Profit Before Tax for the quarter stood at Rs 4,061 million, compared to Rs 3,823 million in the corresponding quarter of the previous financial year.

Bayer CropScience Limited announced its unaudited results for the first quarter (Q1) of Financial Year (FY) 2023-24. For Q1 ended June 30, 2023, the Company registered Revenue from Operations of Rs 17,396 million, compared to Rs 16,674 million in the corresponding period of FY 2022-23. Profit Before Tax for the quarter stood at Rs 4,061 million, compared to Rs 3,823 million in the corresponding quarter of the previous financial year.

Commenting on the quarterly results, Simon-Thorsten Wiebusch, Executive Director, Bayer CropScience Limited said, “In Q1 of FY2023-24 despite the impact of delayed monsoon we continued to see strong growth in Sales and liquidation of our Crop Protection portfolio. As expected, we witnessed Roundup™ price normalization impacting the overall Sales growth of the quarter. Corn seeds continue to yield strong results with volume growth driven by portfolio and better acreages in Kharif.”

Simon Britsch, Chief Financial Officer, Bayer CropScience Limited, while speaking about the quarterly results said, “We have delivered modest reported Revenue from Operations growth of 4% for the quarter and adjusted for the effect of customer incentive programs, we delivered a Revenue from Operations growth of 9 per cent for the quarter despite normalization of Roundup™ pricing. We have continued to proactively manage costs and invest in targeted growth opportunities resulting in increased Profit Before Tax by 6 per cent.”

 Company’s Profit Before Tax for the quarter

Company expects to tap more than 100 billion euros of value in accessible and ag-adjacent markets with estimated peak sales potential of more than 30 billion euros to promote regenerative agricultural practices.

Bayer today announced its Crop Science Division will capitalise on opportunities presented by the shift to regenerative agriculture to grow in adjacent markets in addition to its core business of seeds, traits, crop protection and digital. At its 2023 Innovation Summit, the company identified growth potential in segments like crop fertility, biologicals, biofuels, carbon farming, precision application services as well as digital platforms and marketplaces, all of which are serving the needs of agriculture. Overall, the company expects to access more than 100 billion euros in these adjacent markets annually, in effect doubling the division’s potential market which today stands at more than 100 billion euro for the core portfolio alone. Importantly, by the middle of the next decade, Bayer envisions shaping regenerative agriculture on more than 400 million acres, built on the foundation of its leading agriculture input solutions.

This endeavor, in combination with the division’s leading seeds, traits and crop protection R&D pipeline were showcased in New York, featuring holistic system solutions the company is uniquely positioned to provide, fueling long-term growth of the company as it propels its ambitious growth plan to drive regenerative agriculture.

“We are envisioning an even broader role in agriculture. With the most powerful innovation engine in the industry and leading market positions, Bayer is uniquely set to provide the solutions that farmers need in light of food security and climate change,” said Rodrigo Santos, President of Bayer’s Crop Science Division and Member of the Board of Bayer AG. “We define regenerative agriculture as increasing food production, farm incomes and resilience in a changing climate while renewing nature. Our portfolio will deliver future innovations with regenerative agriculture at the core, and we will explore new market opportunities to further allow farmers to combine productivity, profitability, and sustainability benefits.”

Focus on solutions that drive regenerative agriculture

Farmers around the globe can expect access to industry-leading innovations that not only deliver yield improvements, but which can also regenerate soil and minimize the impact of farming on the climate and broader environment – tailored to the different crops. On the farm of the future, the terabytes of data captured from the field as well as the tons of carbon dioxide sequestered, will be as important to the farmer as the yield that each field produces. Going forward, Bayer will focus its investment on solutions that deliver important pillars of regenerative agriculture. This includes improved productivity, social and economic wellbeing of farmers and communities, conservation of water, mitigation of climate change, improved soil health as well as preservation and restoration of biodiversity.

To this end, Bayer’s core portfolio of crop protection, seeds and traits and digital products is best positioned to grow, and significant advancements are being made annually. The company is investing in its industry-leading pipeline to accelerate the delivery of solutions that growers need. Late-stage transformative technologies are being combined with the annual refresh of the global seed portfolio and the addition of hundreds of new product registrations and formulations every year.

Company expects to tap more than 100

In FY 2022-23, the company registered Revenue from Operations of Rs 51,397 million, compared to Rs 47,344 million in the previous year.

Bayer CropScience Limited announced its results for the financial year (FY) and quarter ended March 31, 2023. In FY 2022-23, the Company registered Revenue from Operations of Rs 51,397 million, compared to Rs 47,344 million in the previous year, registering an overall revenue growth of 9 per cent. Profit Before Exceptional Items & Tax stood at Rs 8,863 million, compared to Rs 7,883 million in the previous year, representing an increase of 12 per cent. Profit Before Tax (After Exceptional Items) increased by 17 per cent from Rs 8,468 million to Rs 9,901 million.

In Q4 of FY 2022-23, the Company registered Revenue from Operations of Rs 9,825 million, compared to Rs 9,633 million in the corresponding quarter of the previous year, delivering a growth of 2 per cent. Profit Before Exceptional Items & Tax for the quarter stood at Rs1,921 million, compared to Rs 1,895 million in the corresponding quarter of the previous year.

Commenting on the quarterly results, Simon-Thorsten Wiebusch, Executive Director, Bayer CropScience Limited said, “Our sales growth in Q4 continued to be driven by strong crop protection sales and consistent performance by our corn seeds business while overcoming some supply constraints faced during the quarter. Although our channel inventory continues to remain at healthy levels, we are witnessing a normalization of Roundup™ prices and availability.”

Speaking on the FY results, Simon Britsch, Chief Financial Officer, Bayer CropScience Limited said, “The steady performance of our crop protection and corn seeds portfolio helped us deliver 9 per cent growth in Revenue from Operations for the financial year. Though headwinds in the form of inflationary pressures led to higher operating expenses, we continued to invest in key initiatives to drive long-term growth. During the year, the company had an exceptional income of Rs 1,038 million arising from the sale of its Environmental Science Business in Q3 of FY 2022-23.”

In FY 2022-23, the company registered Revenue

The company recorded double-digit percentage gains in the Europe/Middle East/Africa and Asia/Pacific regions, but saw sales fall in Latin and North America, mainly due to lower volumes.

The Bayer Group experienced a slow start to 2023 as expected. “Sales were on a par with the exceptionally strong prior-year quarter,” CEO Werner Baumann said on Thursday when presenting the Quarterly Statement for the first quarter. The normalization in the glyphosate business has accelerated, although this effect was largely offset by growth in the other parts of the Crop Science business, he explained. Group earnings were mainly weighed down by the glyphosate business and inflation, and were also impacted by R&D investment at Pharmaceuticals, which remained high.

In the agricultural business (Crop Science), sales declined by 1.1 percent (Fx & portfolio adj.) to 8.351 billion euros. Excluding the glyphosate business, Crop Science sales were up around 8 percent (Fx & portfolio adj.). The division recorded double-digit percentage gains in the Europe/Middle East/Africa and Asia/Pacific regions, but saw sales fall in Latin and North America, mainly due to lower volumes. Sales at Herbicides decreased by 24.3 percent (Fx & portfolio adj.) due to lower volumes and prices for glyphosate-based products. By contrast, Corn Seed & Traits saw sales rise by a substantial 15.8 percent (Fx & portfolio adj.), primarily driven by higher prices in the North America and Europe/Middle East/Africa regions. Sales at Insecticides rose by 12.6 percent (Fx & portfolio adj.), with significant price and volume increases in Europe/Middle East/Africa thanks to Movento™ and in Latin America due to Curbix™ more than offsetting lower volumes in North America. Sales were also up at Soybean Seed & Traits, which registered growth of 1.4 percent (Fx & portfolio adj.) that was mainly driven by higher volumes in Latin America. Sales at Fungicides came in at the prior-year level, with higher prices in all regions offsetting lower volumes in Latin and North America in particular.

EBITDA before special items at Crop Science decreased by 11.0 percent to 3.267 billion euros, mainly due to the fall in sales in Latin and North America. Earnings were also diminished by an increase in particular in the cost of goods sold, which was due to high inflation. There was a positive currency effect of 54 million euros (Q1 2022: 98 million euros). The EBITDA margin before special items declined by 4.3 percentage points to 39.1 percent.

Baumann confirmed the Group outlook for full-year 2023 based on the average monthly exchange rates from 2022. However, for the remainder of the year Bayer sees potential risks mainly arising from the significantly reduced market price expectations for glyphosate-based products, he said. “We continue to expect performance to improve in our other businesses in the second half of the year,” Baumann noted. “Overall, we expect target attainment to come in at the lower end of our guidance.”

The company recorded double-digit percentage gains in

The sustainable crop protection model will be implemented in UP, Bihar, Maharashtra, Karnataka and further expanding pan-India from season to season.

Bayer, a global enterprise with core competencies in the life science fields of agriculture and healthcare has signed a Memorandum of Understanding (MoU) with Superplum, an agri-tech start-up building a digitised farm-to-customer traceable supply chain. This collaboration aims to build and implement a sustainable crop protection model for fruit growers based in UP, Bihar, Maharashtra, Karnataka and expand further to other states from season to season. Over three years, the program aims to benefit 15 thousand smallholder farmers in India by delivering definable economic benefits to all stakeholders. 

As part of the collaboration, Bayer will provide support for domestic and export compliance, implementation of a product schedule to ensure improvement in quality and productivity of the produce, helping in achieving incremental growth in the farmer’s income. Bayer will also focus on developing crop protection packages for fruit crops and training farmers in implementation of these practices. To make it easier to track the farmer’s progress, they will be provided with a passport, to record the crop management practices being realized. Superplum provides consumers full traceability through its scannable QR code and will work on incorporating the information from farmers in its own supply chain.

Superplum’s partnership with Bayer CropScience Limited will focus on guiding partner farmers toward better fruit quality and providing advisory to increase productivity of the produce. They will also ensure proper implementation of crop protection management practices as developed by Bayer. Superplum deploys science and technology to increase the shelf life of the range of fruits through a proprietary multi-faceted approach. Their unique IoT-driven Fresherator, a cold-chain transport system that carries fruit in an environment that can be remotely monitored and controlled, helps reduce wastage and increases the shelf life of the produce without the need for expensive temperature-controlled transport.

Speaking on the partnership, D Narain, President, South Asia, and Global Head of Smallholder Farming for Bayer, said, “Nutritional security along with food security is a critical national and global imperative for the growing population. To this effect, Bayer has launched a global ‘Nutrient Gap Initiative’ that aims to expand access to essential nutrients to 50 million people in underserved communities by 2030. However, we do recognize that to achieve this at scale a collaborative ecosystem is required and to further this critical agenda we are happy to partner with Superplum to create a holistic ecosystem that will help improve fruit growers’ incomes by sustainably enhancing market linkages and ensuring healthy produce for the end consumers.”

During partnership event, Shobhit Gupta, Director and CEO, Superplum said, “Our focus has been on improving consumer choices for fresh produce by providing a fully traceable and MRL tested alternative. With our modern supply chain, we provide full traceability to consumers. With our joint efforts in the field and a technology first approach we will be able to provide full transparency to consumers as well as farmers. Improved practices of post-harvest technology and digital managed supply chain will help to reduce wastages and increase income to farmers.”

The sustainable crop protection model will be

Profit Before Tax (Before Exceptional Items) stood at Rs 829 million, compared to Rs 593 million in the corresponding period of FY 2021-22.

Bayer CropScience Limited announced its unaudited results for the quarter and nine months ended December 31, 2022. In the third quarter (Q3) of Financial Year (FY) 2022-23, Bayer CropScience Limited (BCSL) earned Revenue from Operations of Rs 10,379 million, as compared to Rs 9,901 million in the corresponding period of FY 2021-22. Profit Before Tax (Before Exceptional Items) stood at Rs 829 million, compared to Rs 593 million in the corresponding period of FY 2021-22. Profit Before Tax (After Exceptional Items) stood at Rs 1,836 million as compared to Rs 1,178 million in the corresponding period of FY 2021-22.

For the nine months ended December 31, 2022, BCSL reported Revenue from Operations of Rs 41,572 million, compared to Rs 37,711 million for the corresponding period in FY 2021-22. Profit Before Tax (Before Exceptional Items) for the nine months ended December 31, 2022, stood at ₹ 6,942 million, compared to Rs 5,988 million for the corresponding period in FY 2021-22. Profit Before Tax (After Exceptional Items) stood at Rs 7,949 million as compared to ₹ 6,573 million in the corresponding period of FY 2021-22.

Commenting on the company’s performance, Simon-Thorsten Wiebusch, Executive Director, Bayer CropScience Ltd. said, “Our Q3 revenue growth from operations was driven by corn seeds and herbicides, supported by double-digit liquidation growth of crop protection portfolio and strong recovery in Rabi corn.”

Simon Britsch, Chief Financial Officer, BCSL said, “BCSL concluded the sale of its Environmental Science business in Q3 of FY 2022-23 with an exceptional income of Rs 1,007 million. The portfolio-adjusted Revenue from Operations grew by 6.7 per cent and by 11.8 per cent for the quarter and nine months ended December 31, 2022, respectively. BCSL is continuing on its trajectory with sustained growth investments while focusing on maintaining profitability despite inflationary pressures and other external challenges.”

Profit Before Tax (Before Exceptional Items) stood

Profit Before Tax stood at Rs 2,290 million, compared to Rs 2,195 million in the corresponding period of the previous financial year

 Bayer CropScience Limited announced its unaudited results for the quarter (Q2) and half year ended (H1) September 30, 2022. For Q2 ended September 30, 2022, Bayer CropScience Limited (BCSL) registered Revenue from Operations of Rs14,519 million as compared to Rs 13,651 million in the corresponding period of FY 2021-22. Profit Before Tax stood at Rs 2,290 million, compared to Rs 2,195 million in the corresponding period of the previous financial year.

For the H1 ended September 30, 2022, BCSL reported Revenue from Operations of Rs 31,193 million compared to Rs 27,810 million for the corresponding period in FY 2021-22. Profit Before Tax for the H1 ended September 30, 2022 stood at Rs 6,113 million, compared to Rs 5,395 million for the corresponding period in FY 2021-22.

BCSL concluded the sale of a part of its seed distribution portfolio comprising of mustard, millet, cotton and sorghum seeds in Q3 of FY 2021-22. Considering this, the portfolio adjusted Revenue from Operations grew by 8 per cent for Q2 and 14 per cent for H1 FY 2022-23 while Profit Before Tax increased by 14 per cent for Q2 and 22 per cent for H1 FY 2022-23, respectively.

Commenting on the quarterly and half-yearly results, Simon-Thorsten Wiebusch, Executive Director BCSL said, “Our continuing revenue growth in Q2 was driven largely by strong demand and product liquidation of our crop protection portfolio despite continuing supply chain challenges and a tough hybrid rice season. Supportive commodity prices led to better acreages and strong sales of Corn seeds. A near-normal monsoon in most parts of the country except for the states of Uttar Pradesh, Bihar and West Bengal also aided positive demand momentum. Our efforts of reaching larger segments of smallholder farmers through alternate go-to-market initiatives such as Sahbhaagi and Better Life Farming Centers are also steadily gaining ground.”

Simon Britsch, Chief Financial Officer, BCSL said, “We have maintained our growth momentum in H1. We continue to invest in our business growth opportunities and focus on sustaining margins despite continuing challenges associated with global supplies and rising costs”.

Profit Before Tax stood at Rs 2,290

Profit Before Exceptional Items & Tax for the quarter stood at Rs 1,895 million, compared to Rs 735 million in the corresponding quarter of the previous year.

Bayer CropScience Limited has announced its results for the financial year (FY) and quarter ended March 31, 2022. In FY 2021-22, the Company registered Revenue from Operations of Rs 47,344 million, compared to ₹42,613 million in the previous year, registering an overall revenue growth of 11 per cent. Profit Before Exceptional Items & Tax stood at Rs 7,883 million, compared to Rs 7,894 million in the previous year. Profit after Exceptional Items & Tax increased by 31 per cent from Rs 4,931 million to Rs 6,453 million.

In Q4 of FY 2021-22, the Company registered Revenue from Operations of Rs 9,633 million, compared to Rs 7,337 million in the corresponding quarter of the previous year, delivering a strong growth of 31 per cent . Profit Before Exceptional Items & Tax for the quarter stood at Rs 1,895 million, compared to Rs 735 million in the corresponding quarter of the previous year.

Commenting on the quarterly results, Simon-Thorsten Wiebusch, Executive Director, Bayer CropScience Limited said, “New product launches such as Vayego and Dekalb 9208 and overall strong crop sentiments were key drivers for our sales growth in Q4. This has been achieved overcoming some supply constraints faced during the quarter and partially offsetting inflationary pressure with price increases.”

Speaking on the FY results, Simon Britsch, Chief Financial Officer, Bayer CropScience Limited said, “Effective demand generation, scaling up of alternate business models and new product launches, enabled us to post strong growth of 11 per cent in Revenue from Operations. Our operating costs increases were driven by our continuing investments into strategic initiatives to expand Bayer’s farmer reach of our portfolio and normalization of business activities as travel restrictions eased. During the year, the Company had an exceptional income of Rs 585 million arising from the sale of part of the seed distribution business viz. mustard, cotton, millet and sorghum seeds.

Sharing an outlook for the future, D. Narain, MD & CEO, Bayer CropScience Limited, said, “We continue to focus our efforts to bring innovations across the entire agricultural value chain to drive business growth. To this effect, we have rolled out multiple initiatives some of which have already started showing growth potential.”

Profit Before Exceptional Items & Tax for